Core B: Bioenergetics Mitochondrial dysfunction has long been a consistent observation in Parkinson's disease (PD). To understand the consequences of PD disease causing genetic mutations on the function of mitochondria the Bioenergetics Core B will provide the following analyses to the three projects in this program including: Measuring rates of respiration, oxygen consumption and ATP generation, Measuring calcium dynamics, Measuring reactive oxygen and reactive nitrogen species, measuring the activity of the electron transport chain enzymes and metabolic enzymes, and Measuring plasma versus mitochondria! membrane potential and mitochondria! membrane permeability. The Bioenergetics Core B is a shared resource of the Program. It will measure mitochondria! function, membrane permeability and membrane potential in the presence of AIMP2 and characterize mitochondria! enzymes, oxygen consumption and ATP concentrations in the conditional AIMP2 transgenic mice for Project 1. For Project 2 the Core will measure electron transport chain enzymes and metabolic enzymes and reactive oxygen and reactive nitrogen species in the various models of alpha-synuclein mediated neuronal injury. For Project 3 all measures of mitochondria! function will be conducted to characterize the LRRK2 knockout and LRRK2 transgenic mice. Thus this Core will play a central and integrated role in the investigations in the pathogenesis of PD of this Center.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS038377-14
Application #
8380730
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
14
Fiscal Year
2012
Total Cost
$107,191
Indirect Cost
$41,831
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Hinkle, Jared T; Perepezko, Kate; Rosenthal, Liana S et al. (2017) Markers of impaired motor and cognitive volition in Parkinson's disease: Correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesias. Parkinsonism Relat Disord :
Panicker, Nikhil; Dawson, Valina L; Dawson, Ted M (2017) Activation mechanisms of the E3 ubiquitin ligase parkin. Biochem J 474:3075-3086
Dawson, Ted M; Dawson, Valina L (2017) Mitochondrial Mechanisms of Neuronal Cell Death: Potential Therapeutics. Annu Rev Pharmacol Toxicol 57:437-454
Yun, Seung Pil; Kim, Hyojung; Ham, Sangwoo et al. (2017) VPS35 regulates parkin substrate AIMP2 toxicity by facilitating lysosomal clearance of AIMP2. Cell Death Dis 8:e2741
Sulzer, David; Alcalay, Roy N; Garretti, Francesca et al. (2017) T cells from patients with Parkinson's disease recognize ?-synuclein peptides. Nature 546:656-661
Liddelow, Shane A; Guttenplan, Kevin A; Clarke, Laura E et al. (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541:481-487
Xiong, Yulan; Dawson, Ted M; Dawson, Valina L (2017) Models of LRRK2-Associated Parkinson's Disease. Adv Neurobiol 14:163-191
Gwinn, Katrina; David, Karen K; Swanson-Fischer, Christine et al. (2017) Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program. Biomark Med 11:451-473
Ando, Maya; Fiesel, Fabienne C; Hudec, Roman et al. (2017) The PINK1 p.I368N mutation affects protein stability and ubiquitin kinase activity. Mol Neurodegener 12:32
Lee, Yunjong; Stevens, Daniel A; Kang, Sung-Ung et al. (2017) PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival. Cell Rep 18:918-932

Showing the most recent 10 out of 228 publications